Topical steroids have been used widely, but there is only one well conducted RCT with adequate patient numbers to support their use. In the RCT, which involved 70 patients using
0-2% desoximetasone for 12 weeks, there was a trend to more regrowth in the treatment group, but the complete regrowth rates were higher in the placebo group.24 In an observational study 0-2% fluocinolone acetonide was used under night-time occlusion. Of the 47 patients, of whom only 28 were evaluable, 17 (61%) achieved a satisfactory clinical response after 6 months.25
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.